Voyageur Pharmaceuticals (CVE:VM) Stock Price Up 21.2% – Time to Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report)’s stock price shot up 21.2% during trading on Friday . The company traded as high as C$0.21 and last traded at C$0.20. 292,294 shares changed hands during trading, a decline of 46% from the average session volume of 538,273 shares. The stock had previously closed at C$0.17.

Voyageur Pharmaceuticals Trading Down 10.0 %

The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The business’s fifty day simple moving average is C$0.11 and its 200 day simple moving average is C$0.08. The stock has a market cap of C$25.10 million, a price-to-earnings ratio of -18.00 and a beta of 0.32.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Read More

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.